Document Detail


Use of long-acting injectable risperidone before and throughout pregnancy in schizophrenia.
MedLine Citation:
PMID:  17110011     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Data on the use of long-acting injectable (LAI) risperidone, the first atypical depot antipsychotic, during pregnancy are limited. A 35-year-old woman with schizophrenia was given LAI risperidone before and throughout her pregnancy. She gave birth to a female infant weighing 2230 g at 36 weeks and 6 days of pregnancy, following premature rupture of the membranes. The baby had no congenital malformation and was healthy 8 months postnatal. To our knowledge, this is the first reported use of LAI risperidone throughout an entire pregnancy. In this paper, we discuss the rationale and problems of LAI risperidone use in pregnancy, based on a literature review.
Authors:
Sung-Wan Kim; Ki-Min Kim; Jae-Min Kim; Il-Seon Shin; Hee-Young Shin; Su-Jin Yang; Jin-Sang Yoon
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't     Date:  2006-11-15
Journal Detail:
Title:  Progress in neuro-psychopharmacology & biological psychiatry     Volume:  31     ISSN:  0278-5846     ISO Abbreviation:  Prog. Neuropsychopharmacol. Biol. Psychiatry     Publication Date:  2007 Mar 
Date Detail:
Created Date:  2007-02-12     Completed Date:  2007-04-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8211617     Medline TA:  Prog Neuropsychopharmacol Biol Psychiatry     Country:  England    
Other Details:
Languages:  eng     Pagination:  543-5     Citation Subset:  IM    
Affiliation:
Department of Psychiatry, Chonnam National University Medical School, 5 Hak-dong, Dong-ku, Kwangju 501-746, Republic of Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antipsychotic Agents / administration & dosage*
Drug Administration Schedule
Female
Humans
Injections / methods
Pregnancy
Risperidone / administration & dosage*
Schizophrenia / drug therapy*
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 106266-06-2/Risperidone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prolactin and estradiol serum levels in unmedicated male paranoid schizophrenia patients.
Next Document:  Problems in the supply of antidotes--a view from the pharmaceutical industry.